Although we do not have sufficient sequencing information to determine the mutational signature underpinning IGLL5, it is likely similar to the situation in CLL, where it has a high mutational frequency as consequence of off-target AID activity. Here, AICDA is linked to B-cell chronic lymphocytic leukemia.